Use of selective serotonin reuptake inhibitors for the treatment of childhood panic disorder: A pilot study

Journal of Child and Adolescent Psychopharmacology

Volumn 9, Issue 2, 1999, Pages 73-83

  Renaud, Johanne ^a   Birmaher, Boris ^a   Wassick, Susan C ^a   Bridge, Jeffrey ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CLONAZEPAM; FLUOXETINE; LORAZEPAM; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; HUMAN; MALE; PANIC; PILOT STUDY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0032769538     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1999.9.73     Document Type: Article

References (64)

1. Altshuler LL: Fluoxetine-associated panic attacks. J Clin Psychopharmacol 14:433-434, 1994
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC, American Psychiatric Association, 1994
3. American Psychiatric Association: Practice Guidelines for the Treatment of Patients with Panic Disorder. Am J Psychiatry 155:1-34, 1998
4. Ballenger JC, Carek DJ, Steele JJ, Cornish-Mc Tighe D: Three cases of panic disorder with agoraphobia in children. Am J Psychiatry 146:922-924, 1989
5. Barlow DH: Cognitive-behavioral therapy for panic disorder: Current status. J Clin Psychiatry 58 [suppl 2]:32-36, 1997
6. Barlow DH, Lehman CL: Advances in the psychosocial treatment of anxiety disorders: Implications for national health care. Arch Gen Psychiatry 53:727-735, 1996
7. Beck AT, Epstein N, Brown G, Steer RA: An inventory for measuring clinical anxiety: Psychometric properties. J Con Clin Psychology 56:893-897, 1988
8. Beck AT, Steer RA, Garbin MG: Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Review 8:77-100, 1988
9. Biederman J, Faraone SV, Marrs A, Moore P, Garcia J, Ablon S, Mick E, Gershon J, Kearns ME: Panic disorder and agoraphobia in consecutively referred children and adolescents. J Am Acad Child Adolesc Psychiatry 36:214-223, 1997
10. Biederman J: Clonazepam in the treatment of prepubertal children with panic-like symptoms. J Clin Psychiatry 48:(suppl) 38-41, 1987
11. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J: Childhood and adolescent depression: Review of the past 10 years - Part II. J Am Acad Child Adolesc Psychiatry 35 (12):1575-1583, 1996
12. Birmaher B, Waterman GS, Ryan ND, Cully M, Balach L, Ingram J, Brodsky M: Fluoxetine for childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 33:993-999, 1994
13. Boyer W: Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: A meta-analysis. Int Clin Psychopharmacol 10:45-49, 1995
14. Breier A, Charney DS, Heninger GR: Major Depression in patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:1129-1135, 1994
15. Brent DA, Holder D, Kolko D, Birmaher B, Baugher M, Roth C, Iyengar S, Johnson BA: A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry 54:877-885, 1997
16. Clark DB, Donovan JE: Reliability and Validity of the Hamilton Anxiety Rating Scale in an Adolescent Sample. J Am Acad Child Adolesc Psychiatry 33:354-360, 1994
17. Costello EJ, Farmer EMZ, Angold A, Burns BJ, Erkanli A: Psychiatric disorders among American Indian and White Youth in Appalachia: The Great Smoky Mountains study. Am J Public Health 87:827-832, 1997
18. Davidson JR: Use of Benzodiazpeines in Panic Disorder. J Clin Psychiatry 58(suppl 2), 1997
19. Eaton WW, Kessler RC, Wittchen HU, Magee WJ: Panic and panic disorder in the United States. Am J Psychiatry 151:3, 1994
20. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J: A double-blind, randomized, placebo-contolled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54:1031-1037, 1997
21. Fairbanks JM, Pine DS, Tancer NK, Dummit III ES, Kentgen LM, Asche BK, Klein RG: Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. J Am Acad Child Adolesc Psychiatry 7:17-29, 1997
22. Goodman WK, Kozak MJ, Liebowitz M, White KL: Treatment of obsessive-compulsive disorder with fluvoxamine: A multicentre, double-blind, placebo-controlled trial. Int Clin Psychopharm 11:21-29, 1996
23. Gould RA, Otto MW, Pollack MH: A meta-analysis of treatment outcome for panic disorder. Clin Psychol Review 15:819-844, 1995
24. Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC: A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol 10:57-65, 1995
25. Guy W. ECDEU Assessment Manual of Psychopharmacology. DHEW Publication ADM 76-338. Rockville (MD), National Institute of Mental Health, Psychopharmacology Research Branch, 1976
26. Hamilton M: Diagnosis and rating of anxiety. Br J Psychiatry special publication (3)76-79, 1969
27. Hamilton M: A rating scale for depression. Journal of Neurol Neurosurg Psychiatry 23:56-61, 1960
28. Hayward C, Killen JD, Hammer LD, Litt IF, Wilson DM, Simmonds B, Taylor CB: Pubertal stage and panic attack history in sixth-and seventh-grade girls. Am J Psychiatry 149:1239-1243, 1992
29. Hoehn-Saric R, McLeod DR, Hipsley PA: Effect of fluvoxamine on panic disorder. J Clin Psychopharmacol 13:321-326, 1993
30. Jefferson JW: Antidepressants in Panic Disorder J Clin Psychiatry 58[suppl 2]:20-24, 1997
31. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Amer Statist Assoc 53:457-481, 1958
32. Katzelnik DJ, Kobak KA, Greist JH, Jefferson JW, Mantle JM, Serlin RC: Sertraline for social phobia: A double-blind, placebo-controlled crossover study. Am J Psychiatry 152:1368-1371, 1995
33. Kaufman J, Birmaher B, Brent DA, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36 (7):980-988, 1997
34. Kessler RC, McGonale KA, Shanyang Z, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 51:8-19, 1994
35. Klein RG, Abikoff H, Barkley RA, Campbell M, Leckman JF, Ryan ND, Solanto MV, Whalen CK: Clinical trials in children and adolescents. In: Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines. Edited by Prien RF, Robinson DS. New York, Raven Press, 1994, pp 501-546
36. Kushner MG, Sher JK, Beitman BD: The relation between alcohol problems and the anxiety disorders. Am J Psychiatry 147;685-695, 1990
37. Kutcher S, Mackenzie S: Successful clonazepam treatment of adolescents with panic disorder. J Clinical Psychopharmacol 8:299-301, 1988
38. Last CG, Strauss CC: Panic disorder in children and adolescents. J Anx Disorders 3:87-95, 1989
39. Lecrubier Y, Bakker A, Dubar G, Judge R: A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatrica Scandinavia 95:145-152, 1997
40. Leonard HL, March J, Rickler KC, Allen AJ: Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. J Amer Acad Child Adolesc Psychiatry 36:725-736, 1997
41. Lepine JP, Chignon JM, Teherani M: Suicide attempts in patients with panic disorder. Arch Gen Psychiatry 50:144-9, 1993
42. Lepola U, Leinonen E, Koponen H: Citalopram in the treatment of early-onset panic disorder and school phobia. Pharmacopsychiat 29:30-32, 1996
43. Lewinsohn PM, Hops RH: Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychology 102:133-144, 1993
44. Louie AK, Lewis TB, Lannon RA: Use of low-dose fluoxetine in major depression and panic disorder. J Clin Psychiatry 54:435-438, 1993
45. Macauly JL, Kleinknecht RA: Panic and panic attacks in adolescents. J Anx Disorders 3:221-241, 1989
46. Marshall JR: Comorbidity and its effects on panic disorder. Bulletin of the Menninger Clinic 60(2 Supple A)A 39-53, 1996
47. Matuzas W, Jack E: The drug treatment of panic disorder. Psychiatr Med 9:215-243, 1991
48. Montgomery SA, Rasmussen JG, Tanghoj P: A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the intervention of relapse of depression. Int Clin Psychopharmacol 8:181-188, 1993
49. Moreau DL, Weissman M, Warner V: Panic disorder in children at high risk for depression. Am J Psychiatry 146:1059-1060, 1989
50. Myer JK, Weissman MM, Tischler GL, Holzer III CE, Leaf PJ, Orvashel H, Antony JC, Boyd JH, Burke JD, Kramer M, Stoltzman: Six-month prevalence of psychiatric disorders in three communities. Arch Gen Psychiatry 41:959-967, 1984
51. Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soegaard J, Calberg H, Judge R, Ohrstrom JK, Manniche PM: Paroxetine in the treatment of panic disorder. A randomized, double-blind, placebo-controlled study. Br J Psychiatry 167:374-379, 1995
52. Pollack MH, Otto MW, Sabatino S, Majcher D, Worthington JJ, McArdle ET, Rosenbaum JF: The relationship of childhood anxiety to adult panic disorder: Correlates and influence on course. Am J Psychiatry 153:376-381, 1996
53. Rosenbaum JF: Treatment-resistant panic disorder. J Clin Psychiatry 58 [suppl 2]:61-64, 1997
54. Salge RA, Beck JG, Logan AC: A community survey of panic. J Anx Disorders 2:157-167, 1988
55. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S: A children's global assessment scale (GAS). Arch Gen Psychiatry 40:1228-1231, 1983
56. Shapiro SS, Wilk MB: An analysis of variance test for normality (complete samples). Biometrika 52:591-611, 1965
57. Shear KM, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, Gorman JM, Laszlo AP: Multicenter Collaborative Panic Disorder Severity Scale. Am J Psychiatry 154:1571-1575, 1997
58. Simeon J, Ferguson B, Knott V, Roberts N, Gauthier B, Dubois C, Wiggins D: Clinical, cognitive and neurophysiological effects of alprazolam in children with overanxious and avoidant disorders. J Amer Acad Child Adolesc Psychiatry 31:29-33, 1992
59. Simeon J, Ferguson B: Alprazolam effects in children with anxiety disorders. Can J Psychiatry 32:570-574, 1987
60. Thase ME, Fava M, Hlabreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W: A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 53:777-784, 1996
61. Thyer BA, Parrish RT, Curtis GC, Nesse RM, Cameron OG: Ages of onset of DSM-III anxiety disorders. Comprehensive Psychiatry 26:113-122, 1985
62. Wade AG, Lepola U, Koponen HJ, Pedersen V, Pedersen T: The effect of citalopram in panic disorder. Br J Psychiatry 170:549-553, 1997
63. Whitaker A, Johnson J, Shaffer D, Rapoport JL, Kalikow K, Walsh BT, Davies M, Braiman S, Dolinsky A: Uncommon troubles in young people: Prevalence estimates of selected psychiatric disorders in a nonreferred adolescent population. Arch Gen Psychiatry 47:487-496, 1990
64. Zinner SH: Panic attacks precipitated by sertraline [letter]. Am J Psychiatry 151:147-148, 1994